Amedisys Inc (AMED): Price and Financial Metrics


Amedisys Inc (AMED)

Today's Latest Price: $172.92 USD

10.62 (-5.79%)

Updated Apr 1 4:00pm

Add AMED to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 66 in Medical - Services

See all "A" rated Strong Buy stocks

AMED Stock Summary

  • With a one year PEG ratio of 416.03, Amedisys Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 92.87% of US stocks.
  • The price/operating cash flow metric for Amedisys Inc is higher than 91.27% of stocks in our set with a positive cash flow.
  • With a year-over-year growth in debt of 4,314.24%, Amedisys Inc's debt growth rate surpasses 98.93% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Amedisys Inc, a group of peers worth examining would be WD, EHC, CLGX, HCCI, and USM.
  • AMED's SEC filings can be seen here. And to visit Amedisys Inc's official web site, go to www.amedisys.com.
AMED Daily Price Range
AMED 52-Week Price Range

AMED Stock Price Chart More Charts


AMED Price/Volume Stats

Current price $172.92 52-week high $202.76
Prev. close $183.54 52-week low $106.65
Day low $172.00 Volume 274,704
Day high $185.67 Avg. volume 272,418
50-day MA $178.88 Dividend yield N/A
200-day MA $150.71 Market Cap 5.59B

Amedisys Inc (AMED) Company Bio


Amedisys provides home health and hospice care services. It operates through two segments, Home Health and Hospice. The company was founded in 1982 and is based in Baton Rouge, Louisiana.

AMED Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$172.92$172-6%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Amedisys Inc. To summarize, we found that Amedisys Inc ranked in the 39th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Amedisys Inc ended up being:

  • The business' balance sheet suggests that 5% of the company's capital is sourced from debt; this is greater than only 12.93% of the free cash flow producing stocks we're observing.
  • AMED's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 56.09% of tickers in our DCF set.
  • As a business, Amedisys Inc experienced a tax rate of about 19% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than 85.71% of stocks generating free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-8%
1%-7%
2%-6%
3%-5%
4%-4%
5%-4%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as AMED, try AMGN, MD, PBH, MCK, and CHE.


AMED Latest News Stream


Event/TimeNews Detail
Loading, please wait...

AMED Latest Social Stream


Loading social stream, please wait...

View Full AMED Social Stream

AMED Price Returns

1-mo -1.98%
3-mo 4.09%
6-mo 37.41%
1-year 39.23%
3-year 238.46%
5-year 535.50%
YTD 3.59%
2019 42.53%
2018 122.18%
2017 23.65%
2016 8.42%
2015 33.97%

Continue Researching AMED

Here are a few links from around the web to help you further your research on Amedisys Inc's stock as an investment opportunity:

Amedisys Inc (AMED) Stock Price | Nasdaq
Amedisys Inc (AMED) Stock Quote, History and News - Yahoo Finance
Amedisys Inc (AMED) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8649 seconds.